COMMUNIQUÉS West-GlobeNewswire

-
XORTX Announces Change of Auditor
17/01/2025 - 23:00 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
17/01/2025 - 23:00 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025 - 22:30 -
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025 - 22:30 -
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
17/01/2025 - 22:20 -
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
17/01/2025 - 22:00 -
Scorpius Holdings Cancels Planned Reverse Stock Split
17/01/2025 - 21:13 -
Cannabis Means Business (CMB), New York Global Edition, Opens Registration
17/01/2025 - 20:35 -
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
17/01/2025 - 19:15 -
GUERBET : Bilan semestriel du contrat de liquidité
17/01/2025 - 18:00 -
Bionet America, Inc. Launches Super Air Smart ICU
17/01/2025 - 17:28 -
Abacus Analytics Receives HFMA Peer Review Designation
17/01/2025 - 16:30 -
Legend Senior Living Announces Expansion in Pittsburgh
17/01/2025 - 16:23 -
Enthea to Present at the 2025 Sequire Investor Summit in Puerto Rico
17/01/2025 - 15:00 -
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025
17/01/2025 - 14:00 -
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
17/01/2025 - 13:11 -
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/01/2025 - 13:00 -
Enovis™ Announces Leadership Change to International Surgical Business
17/01/2025 - 12:00 -
Immuron Travelan® continued strong sales growth
17/01/2025 - 12:00
Pages